These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31310954)
1. An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer. Zhang J; Qu Z; Yao H; Sun L; Harata-Lee Y; Cui J; Aung TN; Liu X; You R; Wang W; Hai L; Adelson DL; Lin L Biomed Pharmacother; 2019 Oct; 118():109169. PubMed ID: 31310954 [TBL] [Abstract][Full Text] [Related]
2. Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway. Zheng R; Jiang H; Li J; Liu X; Xu H Curr Cancer Drug Targets; 2017; 17(4):376-385. PubMed ID: 28093061 [TBL] [Abstract][Full Text] [Related]
3. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. Xia A; Li H; Li R; Lu L; Wu X Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933 [TBL] [Abstract][Full Text] [Related]
4. Linc01014 regulates gefitinib resistance in oesophagus cancer via EGFR-PI3K-AKT-mTOR signalling pathway. Fu X; Cui G; Liu S; Zhao S J Cell Mol Med; 2020 Jan; 24(2):1670-1675. PubMed ID: 31785047 [TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells. Songyang Y; Song T; Shi Z; Li W; Yang S; Li D Gene; 2021 Feb; 768():145309. PubMed ID: 33197518 [TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer. Liu P; Xiang Y; Liu X; Zhang T; Yang R; Chen S; Xu L; Yu Q; Zhao H; Zhang L; Liu Y; Si Y Molecules; 2019 Feb; 24(3):. PubMed ID: 30759826 [TBL] [Abstract][Full Text] [Related]
7. Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma. Zhou S; Deng M; Bian X; Shi J; Liang R; Tao M Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):120-127. PubMed ID: 38430032 [TBL] [Abstract][Full Text] [Related]
8. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD Oncotarget; 2016 Nov; 7(47):76827-76839. PubMed ID: 27765907 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway. Gong T; Cui L; Wang H; Wang H; Han N J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734 [TBL] [Abstract][Full Text] [Related]
10. Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway. Chen J; Yuan J; Zhou L; Zhu M; Shi Z; Song J; Xu Q; Yin G; Lv Y; Luo Y; Jia X; Feng L Biomed Pharmacother; 2017 Mar; 87():118-126. PubMed ID: 28049093 [TBL] [Abstract][Full Text] [Related]
11. Ganoderic acid DM induces autophagic apoptosis in non-small cell lung cancer cells by inhibiting the PI3K/Akt/mTOR activity. Xia J; Dai L; Wang L; Zhu J Chem Biol Interact; 2020 Jan; 316():108932. PubMed ID: 31874162 [TBL] [Abstract][Full Text] [Related]
12. Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway. Chen SY; Zhang GC; Shu QJ Pharm Biol; 2021 Dec; 59(1):1294-1304. PubMed ID: 34543169 [TBL] [Abstract][Full Text] [Related]
13. miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1. Zhang T; Wang N Oncol Res; 2018 Sep; 26(8):1191-1200. PubMed ID: 29386087 [TBL] [Abstract][Full Text] [Related]
14. Chinese herbal medicine Fuzheng Kang-Ai decoction sensitized the effect of gefitinib on inhibition of human lung cancer cells through inactivating PI3-K/Akt -mediated suppressing MUC1 expression. Li L; Wang S; Zheng F; Wu W; Hann SS J Ethnopharmacol; 2016 Dec; 194():918-929. PubMed ID: 27989877 [TBL] [Abstract][Full Text] [Related]
15. Luteoloside induces G Zhou M; Shen S; Zhao X; Gong X Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631 [TBL] [Abstract][Full Text] [Related]
16. PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARα/AMPK/AKT/FoxO1 pathway. Wang MS; Han QS; Jia ZR; Chen CS; Qiao C; Liu QQ; Zhang YM; Wang KW; Wang J; Xiao K; Ding XS Acta Pharmacol Sin; 2022 Jan; 43(1):167-176. PubMed ID: 33772142 [TBL] [Abstract][Full Text] [Related]
17. Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines. Li H; Schmid-Bindert G; Wang D; Zhao Y; Yang X; Su B; Zhou C Adv Med Sci; 2011; 56(2):275-84. PubMed ID: 22037177 [TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironment. Choi DY; You S; Jung JH; Lee JC; Rho JK; Lee KY; Freeman MR; Kim KP; Kim J Proteomics; 2014 Aug; 14(16):1845-56. PubMed ID: 24946052 [TBL] [Abstract][Full Text] [Related]
19. Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer. Hsu JL; Leu WJ; Zhong NS; Guh JH Molecules; 2021 Oct; 26(19):. PubMed ID: 34641511 [TBL] [Abstract][Full Text] [Related]
20. A novel hybrid of 3-benzyl coumarin seco-B-ring derivative and phenylsulfonylfuroxan induces apoptosis and autophagy in non-small-cell lung cancer. Dong M; Ye T; Bi Y; Wang Q; Kuerban K; Li J; Feng M; Wang K; Chen Y; Ye L Phytomedicine; 2019 Jan; 52():79-88. PubMed ID: 30599915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]